Baseline characteristics and outcomes stratified by gender or MAP group

AASK participant characteristic	All (n = 149)	Gender			MAP group
		males (n = 82)	females (n = 67)	p	low MAP (≤92 mm Hg) (n = 75)	usual MAP (≤107 mm Hg) (n = 74)	p
Number randomized to low MAP (%)	75 (50)	39 (52)	36 (48)		–	–
Number of men (%)	82 (55)	–	–		39 (52)	43 (58)
Number who did not reach target (%)	11 (7)	10 (12)	1 (1.5)	0.04	4 (5)	7 (10)	0.46
Age at randomization, years	53 ± 11	52 ± 11	54 ± 11	0.27	53 ± 11	53 ± 11	0.93
Baseline MAP, mm Hg	115 ± 18	117 ± 20	112 ± 15	0.05	116 ± 20	112 ± 15	0.13
Body mass index, kg/m2	31 ± 7	31 ± 6	30 ± 7	0.63	31 ± 6	31 ± 7	0.82
Serum creatinine, mg/dl	2.05 ± 0.82	2.33 ± 0.89	1.70 ± 0.55	<0.0001	1.94 ± 0.73	2.15 ± 0.89	0.13
Glomerular filtration rate, ml/min per 1.73 m2	46 ± 13	47 ± 13	45 ± 12	0.17	46 ± 12	46 ± 13	0.82
Total cholesterol, mg/dl	214 ± 47	211 ± 48	217 ± 47	0.46	206 ± 39	222 ± 54	0.04
Average number of daily medications	3.53 ± 1.25	3.81 ± 1.24	3.20 ± 1.19	0.005	3.89 ± 1.15	3.16 ± 1.25	0.0003
Average MAP in first year after randomization	100 ± 7	102 ± 7	98 ± 5	0.003	96 ± 6	104 ± 5	<0.0001

p < 0.05 bolded.